OneMedNet Corp

OneMedNet Corporation (NASDAQ: ONMD) is a global provider of clinical imaging innovation and curator of regulatory-grade imaging real world data. The company connects healthcare providers and patients with life sciences organizations, offering direct access to clinical images and associated contextual patient records. OneMedNet's core offering, iRWD, represents the first real world data solution specifically designed for life science companies that need image-centric data matching their precise cohort specifications.

The company operates through a federated network of approximately 2,130 healthcare sites including hospitals, integrated delivery networks, and imaging centers that provide regulatory-grade data. OneMedNet's technology platform leverages artificial intelligence and machine learning to index and harmonize medical imaging and electronic health records across fragmented data silos. The company's clinical team performs intensive curation to ensure data meets the stringent requirements of life science partners' case selection protocols, with all data remaining de-identified through multi-step quality control processes that go beyond protected health information to include personally identifiable information and site identifiable information.

OneMedNet's competitive advantages stem from its combination of regulatory-grade data quality, on-demand accessibility, and expert clinical curation. The company serves pharmaceutical companies, biotechnology firms, artificial intelligence developers, medical device manufacturers, and clinical research organizations seeking high-quality patient data that explicitly matches their cohort specifications. Approximately ninety percent of healthcare data by size is associated with imaging, yet historically much of this value has remained untapped in clinical archives.

The company was formed through a business combination completed in November 2023 between Data Knights Acquisition Corp and Legacy OneMedNet Solutions Corporation. Legacy OneMedNet was originally incorporated in Delaware in 2015 and operates through a Canadian subsidiary incorporated in British Columbia. The global real world evidence solutions market was valued at approximately $2.6 billion in 2023 and is expected to grow at a compound annual growth rate of 7.4 percent through 2030, driven by increasing demand for enhanced real world evidence capabilities within the life sciences industry and regulatory support from agencies including the FDA and EMA. More information is available at www.onemednet.com.